TrialScientific reports2022

Randomized double-blind placebo-controlled proof-of-concept trial of resveratrol for outpatient treatment of mild coronavirus disease (COVID-19).

Marvin R McCreary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.